federal_register: 01-29210
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01-29210 | Medicare Program; Meeting of the Diagnostic Imaging Panel of the Medicare Coverage Advisory Committee-January 10, 2002 | Notice | This notice announces a public meeting of the Diagnostic Imaging Panel (the Panel) of the Medicare Coverage Advisory Committee (the Committee). The Panel provides advice and recommendations to the Committee about clinical issues. The Panel will hear and discuss presentations from interested persons regarding whether and when it is scientifically justified to use FDG Positron Emission Tomography (PET) or other neuroimaging devices for the diagnosis and patient management of those with Alzheimer's disease (AD). The focus is on the marginal contribution of FDG-PET in various common clinical scenarios to patient outcomes. The following three scenarios will be evaluated: <bullet> Asymptomatic patients who are at high risk of AD due to positive family history. <bullet> Patients with mild cognitive impairment or similar syndrome. <bullet> Patients with dementia. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). | 2001-11-23 | 2001 | 11 | https://www.federalregister.gov/documents/2001/11/23/01-29210/medicare-program-meeting-of-the-diagnostic-imaging-panel-of-the-medicare-coverage-advisory | https://www.govinfo.gov/content/pkg/FR-2001-11-23/pdf/01-29210.pdf | Health and Human Services Department; Centers for Medicare & Medicaid Services | 221,45 | This notice announces a public meeting of the Diagnostic Imaging Panel (the Panel) of the Medicare Coverage Advisory Committee (the Committee). The Panel provides advice and recommendations to the Committee about clinical issues. The Panel will hear... |